Figure 5From: The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical studyChange of PI/I ratio. Whereas mitiglinide did not affect the PI/I ratio, glimepiride tended to increase this parameter.Back to article page